Received 31 August 2010
aFaculty of Chemistry and Life Science, Xianning University, Xianning 437100, Hubei, People's Republic of China,bInstitute of Medicinal Chemistry, Hubei Medical University, Shiyan 442000, Hubei, People's Republic of China, and cDepartment of Oncology, Renmin Hospital, Hubei Medical University, Shiyan 442000, Hubei, People's Republic of China
Correspondence e-mail: email@example.com
In the title compound, C20H15N3O2·C18H15OP, the pyrimidinone heterocycle and the fused phenyl ring are inclined at 1.92 (7)°. Only the hydroxy group is involved in hydrogen bonding, whereas the amino group is shielded from potential acceptors.
Data collection: SMART (Bruker, 2000); cell refinement: SAINT (Bruker, 2000); data reduction: SAINT; program(s) used to solve structure: SHELXS97 (Sheldrick, 2008); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008); molecular graphics: SHELXTL (Sheldrick, 2008); software used to prepare material for publication: SHELXTL .
Supplementary data and figures for this paper are available from the IUCr electronic archives (Reference: BT5345 ).
The authors are grateful to Hubei Medical University Education Committee (grant No. 2009QJ12) for financial support and acknowledge the Sophisticated Analytical Instrument Facility, Central China Normal University, Wuhan, for the data collection.
Bruker (2000). SMART and SAINT. Bruker AXS Inc., Madison, Wisconsin, USA.
Sheldrick, G. M. (2001). SADABS. University of Goöttingen, Germany.
Sheldrick, G. M. (2008). Acta Cryst. A64, 112-122.
Yang, X. H., Wu, M. H., Sun, S. F., Ding, M. W., Xie, J. L. & Xia, Q. H. (2008). J. Heterocycl. Chem. 45, 1365-1369.